Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease.

Molina AM, Tickoo SK, Ishill N, Trinos MJ, Schwartz LH, Patil S, Feldman DR, Reuter VE, Russo P, Motzer RJ.

Am J Clin Oncol. 2011 Oct;34(5):454-9. doi: 10.1097/COC.0b013e3181f47aa4.

2.

Systemic therapy for non-clear cell renal cell carcinomas: a systematic review and meta-analysis.

Vera-Badillo FE, Templeton AJ, Duran I, Ocana A, de Gouveia P, Aneja P, Knox JJ, Tannock IF, Escudier B, Amir E.

Eur Urol. 2015 Apr;67(4):740-9. doi: 10.1016/j.eururo.2014.05.010. Epub 2014 Jun 2. Review.

PMID:
24882670
3.

Cytotoxic chemotherapy in the treatment of advanced renal cell carcinoma in the era of targeted therapy.

Diamond E, Molina AM, Carbonaro M, Akhtar NH, Giannakakou P, Tagawa ST, Nanus DM.

Crit Rev Oncol Hematol. 2015 Dec;96(3):518-26. doi: 10.1016/j.critrevonc.2015.08.007. Epub 2015 Aug 13. Review.

PMID:
26321263
4.

Metastatic bone disease: A review of survival, prognostic factors and outcomes following surgical treatment of the appendicular skeleton.

Kirkinis MN, Lyne CJ, Wilson MD, Choong PF.

Eur J Surg Oncol. 2016 Dec;42(12):1787-1797. doi: 10.1016/j.ejso.2016.03.036. Epub 2016 Apr 19. Review.

PMID:
27499111

Supplemental Content

Support Center